An Italian, observational, multicenter, retrospective study evaluating efficacy and safety of T-DM1 in heavily pretreated HER2-positive advanced breast cancer patients.

Trial Profile

An Italian, observational, multicenter, retrospective study evaluating efficacy and safety of T-DM1 in heavily pretreated HER2-positive advanced breast cancer patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2016

At a glance

  • Drugs Trastuzumab emtansine (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Jul 2016 New trial record
    • 07 Jun 2016 Results of heavily pretreated patients (n=119) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top